Supplementary Figure 1 from Clinical Context Shapes the Relationship between Genomic Alterations and Response to AR Inhibitors and Chemotherapy in Metastatic Prostate Cancer

<p>Supplementary Figure 1. Exploration of mHSPC and mCRPC cohort.</p>